Analytic Reviews : Enterococcal Infections: Resistance Mechanisms,Treatment Strategies,and Hospital Issues

Arduino RC , Murray BE Enterococcus antimicrobial resistance Prin Pract Infect Dis 1994,2 3-14

Centers for Disease Control Nosocomial enterococci resistant to vancomycin-United States, 1989-1993 MMWR 1993, 42 597-599

Chenoweth C. , Schaberg D. The epidemiology of enterococci Eur J Clin Microbiol Infect Dis 1990,9 80-89

Morrison AJ , Wenzel RP Nosocomial urinary tract infections due to enterococcus ten years experience at a university hospital Arch Intern Med 1986 ,146 1549-1551

Moellering RC Enteroccoccus species, Streptococcus bovis, and Leuconoctoc species In Mandell GL , Bennett JE , Dolin R , eds. Mandell, Douglas, and Bennett's principles and practices of infectious diseases , 4th ed New York Churchill Livingstone, 1995 1826-1834

Hooton TM , Stamm WE Diagnosis and treatment of uncomplicated urinary tract infection Infect Dis Clin N Am 1997, 11 551-582

Murray BE The life and times of the enterococcus Clin Microbiol Rev 1990,3 46-65

Willey SH , Hindes RG , Eliopoulos GM , et al Effects of clindamycin, gentamicin and other antimicrobial combinations against enterococci in an experienced intraabdominal abscess model Surg Gynecol Obstet 1989,169 199-201

Burnett RJ , Haverstock DC , Dellinger EP , et al Definition of the role of enterococcus in intraabdominal infection analysis of a prospective randomized trial Surgery 1995,118 716-721

Moellering RC Emergence of enterococcus as a significant pathogen Clin Infect Dis 1992,14.1173-1178

Whiteside M. , Moore J. , Ratzan K. An investigation of enterococcal bacteremia Am J Infect Control 1983,11 125-129

Maki DG , Agger WA Enterococcal bacteremia clinical features, the risk of endocarditis, and management Medicine 1988,67 248-269

Weinstein M. , Towns ML , Quartey SM , et al The clinical significance of positive blood cultures in the 1990's a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults Clin Infect Dis 1997,24 584-602

Mandell G. , Kaye D. , Levinson ME Enterococcal endocarditis An analysis of 38 patients at the New York Hospital -Cornell Medical Center Arch Intern Med 1970 ,125 258-264

Rice LB , Calderwood SB , Eliopoulos GM , et al Enterococcal endocarditis a comparison of prostatic and native valve disease Rev Infect Dis 1991,13.1-13

Reiner NE , Gopalaknsha KV Enterococcal endocarditis in heroin addicts JAMA 1976,235 1861-1863

Horvitz RA , Von Graevemtz A. A clinical study of the role of enterococci as sole agent of wound and tissue infections. Yale J Biol Med 1977 ,50 391-395

Berk SL , Verghese A. , Holtsclaw SA Enterococcal pneumoma occurrence in patients receiving broad-spectrum antibiotic regimens and enteral feeds Am J Med 1983,74 153-154

Bayer AS , Seidel JS , Yoshikawa TT Group D enterococcal meningitis Clinical and therapeutic considerations with report of three cases and review of the literature Arch Intern Med 1976, 136·883-886

McNeeley DF , Saint-Louis F. , Noel GJ Neonatal enterococcal bacteremia an increasingly frequent event with potentially untreatable pathogens Pediatr Infect Dis 1996,15 800-805

Coudron PE , Mayhall CG , Facklam RR Streptococcus faecium outbreak in a neonatal intensive care unit J Clin Microbiol 1984,20 1044-1048

Moellering RC , Watson BK , Kunz LJ Endocarditis due to group D streptococci Comparison of disease caused by Streptococcus bovis with that produced by the enterococci . Am J Med 1974,57 239-250

Eliopoulos GM Antibiotic resistance in enterococcus species an update Curr Clin Topics Infect Dis 1996 ,16 21-51

Fontana R. , Cerini R. , Longoni P. Identification of a streptococcal penicillin-binding protein that reacts very slowly with penicillin Bacteriol 1983,55 1343-1350

Hodges TL , Zighelboim-Daum S. , Eliopoulos GM , et al Antimicrobial susceptibility changes in Enterococci faecalis following various penicillin exposure regimens Antimicrob Agents Chemother 1992;36 121-125

Grayson ML , Eliopoulos GM , Wennerstein CB et al Increasing resistance to beta-lactam antibiotics among clinical isolates of enterococcus faecium a 22 year review at one institution Antimicrob Agents Chemother 1991,35 2180-2184

Eliopoulos GM Enterococcal endocarditis In Kaye D , ed Infective endocarditis, 2nd ed New York Raven Press, 1992 209-223

Baldassarre JS , Kaye D. Principles and overview of antibiotic therapy In Kaye D , ed Infective endocarditis, 2nd ed New York Raven Press, 1992·169-190

Murray BE Beta-lactamase producing enterococci Antimicrob Agents Chemother 1992,36 2355-2359

Eliopoulos GM The 10 most common questions about resistant entcrococcal infections. Infect Dis Clin Pract 1996,3 125-132

Murray BE , Singh KV , Markowitz SM , et al Evidence of clonal spread of a single strain of beta-lactamase-producing Enterococci (Streptococci) faecalis to six hospitals in five states J Infect Dis 1991,163 780-785

Rhinehart E. , Smith NE , Wennerstein CB , et al Rapid dissemination of beta-lactamase producing, aminoglycoside-resistant Enterococcus faecalis among patients and staff on an infant-toddler surgical ward N Engl J Med 1990,323 1814-1818

Wells VD , Wong ES , Murray BE Infections due to beta-lactamase-producing, high level gentamicin-resistant Enterococcus faecalis Ann Intern Med 1992,116 285-292

Harvard CW , Garrod LP , Waterworth PM Deaf or dead? A case of subacute bacterial endocarditis treated with penicillin and neomycin Br Med J 1959,1 688-689

Moellering RC The Garrod lecture—the enterococcus a classic example of the impact of antimicrobial resistance on therapeutic options J Antimicrob Chemother 1991, 28 1-12

Horodniceanu T. , Bougueleret L. , El-Solh N. , et al High-level plasmid-borne resistance to gentamicin in Streptococcusfaecalis subsp zymogenes Antimicrob Agents Chemother 1979; 16 686-689

Nccls Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed Approved standard NCCLS document, 1997, 17 M7-A4

Kim MJ , Weiser M. , Gottschall S. , et al Identification of Streptococcus faecalis and Streptococcus faecium and susceptible studies with newly developed antimicrobial agents J Clin Microbiol 1987,25 787-790

Uttley AH , Collins CH , Naidoo J. , et al Vancomycin-resistant enterococci Lancet 1988,1 57-58

Jones RN , Sader HS , Erwin ME Emerging multiply resistant enterococci among clinical isolates Prevalence data from 97 medical center surveillance study in the United States Diagn Microbiol Infect Dis 1995,21 85-93

Archibald L. , Phillips L. , Monnet D. , et al Antimicrobial resistance in isolates from inpatients and outpatients in the United States increasing importance of the intensive care unit. Clin Infect Dis 1997,24 211-215

Jones RN , Marshall SA , Pfaller MA , et al Nosocomial enterococcal blood stream infections in the SCOPE program antimicrobial resistance, species occurrence, molecular testing results, and laboratory testing accuracy Diagn Microbiol Infect Dis 1997,29 95-102

43 Papamcolaou GA, Meyers BR , Meyers J. Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients Clin Infect Dis 1996,23 760-766

Tokars JI , Miller ER National surveillance of dialysis-associated diseases in the United States, 1996 Atlanta, GA Public Health Service Department of the Health and Human Services, 1998 1-59

Newell KA , Millis JM , Arnow PM , et al. Incidence and outcome of infection by vancomycin-resistant enterococcus following orthotopic liver transplantation Transplantation 1998,65 439-442

Morris JG , Shay DK , Hebden JN Enterococci resistance to multiple antimicrobial agents, including vancomycin establishment of endemicity in a university medical center Ann Intern Med 1995,123 250-259

Shay DK , Maloney SA , Montecalvo M. Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections J Infect Dis 1995,172 993-1000

Slaughter S. , Hayden M. , Nathan C. , et al A comparison of the effect of universal use of gloves and gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical intensive care unit. Ann Intern Med 1996,125 448-456

Dever LL , China C. , Eng RH , et al Vancomycin-resistant Enterococcus faecium in a veterans affairs medical center associated with antibiotic usage Am J Infect Control 1998,26 40—46

Edmond MB , Ober JF , Weinbaum DL , et al Vancomycin-resistant Enterococcus faecaum bacteremia risk factors for infection Clin Infect Dis 1995,20 1126-1133

Fridkin SK , Yokoe DS , Whitney CG , et al Epidemiology of a dominant clonal strain of vancomycin-resistant Enterococcus faecium as separate hospitals in Boston, Massachusetts J Clin Microbiol 1998,36 965-970

Bonten M. , Hayden M. , Nathan C. , et al Epidemiology of colonization of patients and environment with vancomycin-resistant enterococci Lancet 1996 ,348 1615-1619

Swenson JM , Clark NC , Ferraro MJ , et al Development of a standardized screening method for detection of vancomycin-resistant enterococci J Clin Microbiol 1994,32 1700-1704

Ehopoulos GM Vancomycin resistant enterococci mechanism and clinical relevance. Infect Dis Clin N Am 1997 ,11 851-865

55 Perichon B, Reynolds P. , Courvalin P. VanD-type glycopeptide-resistant Enterococcus faecium BM4339 Antimicrob Agents Chemother 1997,41 2016—2018

Hayden MK , Trenholme GM , Schultz JE , et al In vivo development of teicoplanin resistance in a vanB Enterococcus faecium isolate J Infect Dis 1993,167 1224-1227

Dutka-Malen S. , Evers S. , Courvalin P. Detection of glycopeptide resistance genotypes and identification to the species level of relevant enterococci by PCR J Clin Microbiol 1995, 33 24-27

Beauregard DA , Williams DH , Gwynn MN , et al Dimenzation and membrane anchors in extracellular targeting of vancomycin group antibiotics Antimicrob Agents Chemother 1995,39 781-785

Bugg Tdh , Dutka-Malen S. , Arthur M. Identification of vancomycin resistance protein vanA as a D-alanine D-alanine ligase of altered substrate specificity Biochemistry 1991,30 2017-2021

Evers S. , Sahm DF , Courvalin P. The vanB gene of vancomycin-resistant Enterococcus faecalis V583 is structurally related to genes encoding D-ala D-ala ligases and glycopeptide-resistance proteins vanA and vanC Gene 1993,124 143-144

Sahm DF , Free L. , Handwerger S. Inducible and constitutive expression of vanC-1 encoded resistance to vancomycin in Enterococcus gallinarum Antimicrob Agents Chemother 1995, 39 1480—1484

Frieden TR , Munsiff SS , Low DE Emergence of vancomycin-resistant enterococci in New York City Lancet 1993,342 76-79

Wells CL , Juni BA , Cameron SB Stool carriage, clinical isolations, and mortality during an outbreak of vancomycm-resistant enterococci in hospitalized medical and/or surgical patients Clin Infect Dis 1995,21 45-50

Montecalvo M. , Seiter K. , Carbonaro CA Effect of novobiocin-containing antimicrobial regimens on infection and colonization with vancomycm-resistant Enterococcus faecium Antimicrob Agents Chemother 1995,39 794

Guiot Hfl , Peeterman WE , Sebens FW Isolation of vancomycin-resistant enterococci in haematology patients Eur J Clin Microbiol Infect Dis 1991,10 32-34

Van der Auwera P. , Pensart N. , Korten V. Influence of oral glycopeptides on the fecal flora of human volunteers selection of highly glycopeptide-resistant enterococci . J Infect Dis 1996;173 1129-1136

Gordts B. , Van Landuyt H. , Ieven M. , Vandamme P. , Goossens H. Vancomycin-resistant enterococci colonizing the intestinal tracts of hospitalized patients J Clin Microbiol 1995,33 2842-2846

Boyce JM , Mermel LA , Zervos MJ Controlling vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 1995, 16.634—637

Livorneses LI , Dias S. , Samel C. , et al Hospital-acquired infections with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers Ann Intern Med 1992,117-112-116

Centers for Disease Control Recommendations for preventing the spread of vancomycin resistance Federal Register 1994,59 25758-25763

Nightingale J. , Chaffee BW , Colvin CL , et al Retrospective evaluation of vancomycin use in a university hospital Am J Hosp Pharmacol 1987,44 1807-1809

Handwerger S. , Raucher B. , Altarac D. , et al Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin Clin Infect Dis 1993,16 750-755

Montecalvo M. , Lencastre H. , Carraher M. , et al Natural history of colonization with vancomycin-resistant Enterococcus faecium Infect Control Hosp Epidemiol 1995,16 680-685

Chia Jks , Nakata MM , Park SS Use of bacitracin therapy for infection due to vancomycin-resistant Enterococcus faecium Clin Infect Dis 1995,21 1520

Schaberg DR , Culver DH , Gaynes RP Major trends in the microbiology and etiology of nosocomial infections Am J Med 1991,91 72S-75S

Hoge CW , Adams J. , Buchanan B. Enterococcal bacteremia to treat or not to treat, a reappraisal Rev Infect Dis 1991, 13 600-605

Bisno AL , Dismukes WE , Durack DT , et al Antimicrobial treatment of infective endocarditis due to viridans streptococci, enterococci, and staphylococci JAMA 1989,261 1471-1474

Tsai SF , Zervos MJ , Clewell DB , et al A new high-level gentamicin resistance gene, aph(2")-Id, in Enterococcus spp Antimicrob Agents Chemother 1998,42 1229-1232

Wilson WR , Wilkowske CJ , Wnght AJ Treatment of streptomycin susceptible and streptomycin-resistant enterococcal endocarditis Ann Intern Med 1984,100 816-823

Watanakunakorn C. , Patel R. Comparison of patients with enterococcal bacteremia due to strains with/without high-level resistance to gentamicin Clin Infect Dis 1993, 17.74-78

Eliopoulos GM , Thauvin-Eliopoulos C. , Moellering RC Contributions of animal models in the search for effective therapy for endocarditis with high-level resistance to gentamicin Clin Infect Dis 1996;15:58-62

Mekonen ET , Noskin GA , Hacek DM , et al Successful treatment of persistent bacteremia due to vancomycin-resistant, ampicillin-resistant Enterococcus faecium Microbial Drug Resis 1995,1 249-253

Norris AH , Reilly JP , Edenstein PH Chloramphenicol for the treatment of vancomycin-resistant enterococcal infections . Clin Infect Dis 1995,20.1137-1144

Linden PK , Pasculle AW , Manez R. Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E faecium Clin Infect Dis 1998,22 663-670

Caron F. , Pestel M. , Kitzis MD Comparison of different Beta-lactam-glycopeptide-gentamicin combinations for an experimental endocarditis caused by a highly beta-lactam-resistant and highly glycopeptide-resistant isolate of Enterococcus faecium J Infect Dis 1998,17 106-112

Brandt C. , Rouse M. , Laue N. , et al Effective treatment of multidrug-resistant enterococcal experimental endocarditis with a combination of cell wall-active agents J Infect Dis 1996, 173 909-913

Moellering RC Vancomycin-resistant enterococcus more questions than answers—What therapeutic options do we have? 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, 1998

Chow JW , Davidson A. , Sanford E. , et al Superinfection with Enterococcus faecalis during quinupristin/dalfopristin therapy Clin Infect Dis 1997,24 91-92

Linden PK , Pasculle AW , McDevitt D. , et al Effect of quinupristin/dalfopristin on the outcome of vancomycin-resistant Enterococcus faecium bacteremia comparison with a control cohort J Antimicrob Chemother 1997,39(suppl A) 145-151

Mercier RC , Penzak SR , Rybak MJ In vitro activities of an investigational quinolone, glycylcycline, glycopeptide, streptogramin, and oxazolidinone tested alone and in combinations against vancomycin-resistant Enterococcus faecium Antimicrob Agents Chemother 1997,41 2573-2575

Abramowitcz M. Grepafloxacin—a new fluoroquinolone Med Lett 1998;40 17-18

Abramowitcz M. Sparfloxacin and levofloxacin Med Lett 1997,39 41-42

Abramowitcz M. Trovafloxacin Med Lett 1998,40 30-31

Schulin T. , Thauvin-Eliopoulos C. , Moellering RC , et al In vivo activity of new oxazolidone antimicrobial agents against enterococci in a rat intraabdominal abscess model [abstract] 37th Interscience Conference on Antimicrobial Agents and Chemotherapy Toronto, Canada, 1997 Abstract no. B-99.

Mercier RC , Houlihan HH , Rybak MJ Pharmacodynamic evaluation of a new glycopeptide, LY333328, and in vitro activity against Staphylococcus aureus and Enterococcus faecium Antimicrob Agents Chemother 1997,41 1307-1312